Clinical trial
Observational Study for Left Main Disease Treatment
NCT01341327 · Seung-Jung Park, Other · Recruiting
Key facts
| NCT number | NCT01341327 |
|---|---|
| Title | Observational Study for Left Main Disease Treatment |
| Official title | A GLOBAL, MULTICENTER, PROSPECTIVE, REAL WORLD OBSERVATIONAL STUDY FOR LEFT MAIN DISEASE TREATMENT |
| Acronym | IRIS-MAIN |
| Lead sponsor | Seung-Jung Park, Other |
| Collaborators | CardioVascular Research Foundation, Korea |
| Status | Recruiting |
| Study type | Observational |
| Conditions | Coronary Artery Disease |
| Enrollment | 10,000 |
| Start date | Jul 1, 2007 |
| Primary completion | Dec 1, 2032 |
| Completion | Dec 1, 2033 |
| First posted | Apr 25, 2011 |
| Last update posted | Jun 26, 2024 |
| Countries | China, Malaysia, South Korea, Taiwan, Thailand |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: